AR
AREV Life Sciences Global Corp
AREVF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $22.6K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.46x
P/FCF N/A
P/FFO N/A
Growth
0 /100
Declining Rev. growth 36.81%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak FCF margin 745.62%
Op. margin 2,827.74%
Gross margin 59.33%
Quality
61 /100
Average ROA 571.63%
Asset turnover 0.19x
ROIC 150.34%
Debt
50 /100
Moderate Int. coverage -236.17x
Net debt/EBITDA -0.02x
Current ratio 0.06x
Stability
16 /100
Unstable Profitable years 0
EPS volatility 39.57%
Beta 4.94x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AREVF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Michael C. Withrow
Employees
19,534
Headquarters
Coquitlam